The lack of effective treatments for pulmonary diseases presents a significant global health
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …

Various nanoparticles are used in the discovery of new nanomedicine to overcome the
shortages of conventional drugs. Therefore, this article presents a comprehensive and up-to …

Despite significant research progress in substantiating the therapeutic merits of
nanomedicines and the emergence of sophisticated nanotechnologies, the translation of this …

With the development of nanotechnology and confronting the problems of traditional
pharmaceutical formulations in treating lung diseases, inhalable nano-formulations have …

Remdesivir (RDV) is an antiviral used in potential treatment of SARS-COV-2 infection during
the COVID-19 pandemic worldwide. However, it is still limited to IV administration for …

The supercritical antisolvent-fluidized bed coating process (SAS-FB) shows great potential
as a technique to manufacture dry powder inhaler (DPI) that incorporate nanodrugs onto …

In the last decade, nanocarriers have been widely used to target specific organs and
disorders of any kind. Nonetheless, the commercialization of nanocarriers for many …

Traditional vaccines can be classified into inactivated vaccines, live attenuated vaccines,
and subunit vaccines given orally or via intramuscular (IM) injection or subcutaneous (SC) …

Lung cancer is a leading cause of global cancer mortality, often treated with
chemotherapeutic agents. However, conventional approaches such as oral or intravenous …

Inhaled nanoparticle (NP) therapy poses intricate challenges in clinical and
pharmacodynamic realms. Recent strides have revolutionized NP technology by enabling …